Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

ICON expands services through Oxford Outcomes acquisition

ICON, a global provider of outsourced development services to the medical device industry, has expanded its Late Phase and Outcomes Research services through the acquisition of Oxford Outcomes, an international health outcomes consultancy.

ICON‘s executive vice president of Business Development Elizabeth Thiele has been appointed as president of the newly specialised service unit.

ICON CEO Peter Gray said the biopharmaceutical industry and regulators are more than ever before using post-marketing studies to demonstrate efficacy and safety, as well as demonstrating the economic value of products.

"Oxford Outcomes has grown to become a leader in its field and brings to ICON a wealth of expertise in the fields of health economics, outcomes research and epidemiology and a strong reputation for excellent client service," Gray said.